In vivo study indicated that vitamin E upregulated CYPs, including CYP1A1 and CYP1B1 which highly expressed in prostate cancer, increased ROS production and led to the mutation of prostate cells [41]. This evidence concerns the gene CYP1B1 and prostate carcinoma.